Multinational drug firms’ revenues fall 3% on slump

Twenty-six multinational drug makers saw their combined sales drop 2.6 percent in 2012 from a year earlier, an online pharmaceutical information provider said Friday, pointing to their troubles stemming from the government-mandated price cut for drugs in April of last year.

The combined sales of the 26 drug firms fell 2.6 percent on-year to 4.33 trillion won in 2012, according to Yakup.com. ...